Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Dopamine Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine < Dopamine Agents < Dopamine Agonists  Facettes :

List of bibliographic references indexed by Dopamine Agents

Number of relevant bibliographic references: 137.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000002 (2015) Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000109 (2015) Eugene V. Mosharov [États-Unis] ; Anders Borgkvist ; David SulzerPresynaptic effects of levodopa and their possible role in dyskinesia.
000128 (2015) Marjan Jahanshahi [Royaume-Uni] ; Ignacio Obeso ; Christelle Baunez ; Manuel Alegre ; Paul KrackParkinson's disease, the subthalamic nucleus, inhibition, and impulsivity.
000213 (2015) Oscar S. Gershanik [Argentine]Improving L-dopa therapy: the development of enzyme inhibitors.
000599 (2014) Alice Laudisio [Italie] ; Davide L. Vetrano ; Eleonora Meloni ; Diego Ricciardi ; Francesco Franceschi ; Anna Rita Bentivoglio ; Roberto Bernabei ; Giuseppe ZuccalàDopaminergic agents and nutritional status in Parkinson's disease.
000638 (2014) Silke Appel-Cresswell [Canada] ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex RajputClinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.
000732 (2013) Ralf Reilmann [Allemagne]The pridopidine paradox in Huntington's disease.
000767 (2013) Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000861 (2013) Alex A. Macdonald [Canada] ; Oury Monchi ; Ken N. Seergobin ; Hooman Ganjavi ; Ruzbeh Tamjeedi ; Penny A. MacdonaldParkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
000917 (2013) Joseph Jankovic [États-Unis]Medical treatment of dystonia.
000933 (2013) Roser Pons [Grèce] ; Dimitris Syrengelas ; Sotiris Youroukos ; Irene Orfanou ; Arqirios Dinopoulos ; Bru Cormand ; Aida Ormazabal ; Angels Garzía-Cazorla ; Mercedes Serrano ; Rafael ArtuchLevodopa-induced dyskinesias in tyrosine hydroxylase deficiency.
000934 (2013) Erwan Bézard ; C Warren Olanow ; José A. ObesoLevodopa-induced dyskinesias in the absence of nigrostriatal degeneration.
000945 (2013) Pauline Belujon ; Anthony A. GraceL-DOPA treatment duration versus Parkinson's Disease progression: The dorsal-ventral divide
000973 (2013) Aikaterina Angeli [Royaume-Uni] ; Niccolo E. Mencacci [Royaume-Uni, Italie] ; Raquel Duran [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Zinovia Kefalopoulou [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Sarah Rusbridge [Royaume-Uni] ; Jennifer Foley [Royaume-Uni] ; Priyanka Pradhan [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Tom Foltynie [Royaume-Uni]Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation
000A19 (2013) David E. Vaillancourt [États-Unis] ; Daniel Schonfeld [États-Unis] ; Youngbin Kwak [États-Unis] ; Nicolaas I. Bohnen [États-Unis] ; Rachael Seidler [États-Unis]Dopamine overdose hypothesis: Evidence and clinical implications
000B26 (2013) A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.
000B63 (2012) Katrina L. Paumier [États-Unis] ; Andrew D. Siderowf ; Peggy Auinger ; David Oakes ; Lalitha Madhavan ; Alberto J. Espay ; Fredy J. Revilla ; Timothy J. CollierTricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease.
000C81 (2012) Robert Iansek ; Mary DanoudisOral formulations of L-dopa and continuous dopaminergic stimulation.
000D72 (2012) Jessie Theuns [Belgique] ; David Crosiers ; Luc Debaene ; Karen Nuytemans ; Bram Meeus ; Kristel Sleegers ; Dirk Goossens ; Ellen Corsmit ; Ellen Elinck ; Karin Peeters ; Maria Mattheijssens ; Barbara Pickut ; Jurgen Del-Favero ; Sebastiaan Engelborghs ; Peter Paul De Deyn ; Patrick Cras ; Christine Van BroeckhovenGuanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia.
001245 (2011) Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards ; Alfonso Fasano ; Andrea E. CavannaThe prevalence and clinical characteristics of punding in Parkinson's disease.
001269 (2011) Evžen Růži Ka [République tchèque] ; Kate Ina Zárubová [République tchèque] ; John G. Nutt [États-Unis] ; Bastiaan R. Bloem [Pays-Bas]“Silly Walks” in Parkinson's disease: Unusual presentation of dopaminergic‐induced dyskinesias

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Dopamine Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Dopamine Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agents
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024